Product Description:
Favipira is the preparation of favipiravir. Favipira is a drug the use of which is considered only when there is an outbreak of novel or re-emerging influenza virus infections in which other anti-influenza virus agents are not effective or insufficiently effective, and the government decides to use the drug as a countermeasure against such influenza’s viruses. When administering the drug, obtain the latest information including government’s direction of countermeasures a gain such influenza viruses, and prescribe only to appropriate patients. In present situation Favipira is using to treat COVID-19 patients. This drug is showing hope for the COVID-19 patients.
Product Features:
Product Name | : | Favipira |
Generic Name | : | Favipiravir |
Formulation | : | Tablet |
Available Pack Size | : | 200 mg (Oral Tablet) |
Available Strength | : | 2 x 10’s |
Registrations | : | Bangladesh |